News
- Author:
- Randy Dotinga
Publish date: February 21, 2023
It’s highest in less-developed countries, with about a third of patients affected in the U.S.
News
- Author:
- Randy Dotinga
Publish date: February 17, 2023
A 30-year Dutch population study highlights the medical challenges facing patients with CLL, who are now living longer.
News
- Author:
- Randy Dotinga
Publish date: February 13, 2023
New findings surprised a study researcher since the adverse outcomes weren’t related to prematurity.
News
- Author:
- Randy Dotinga
Publish date: February 10, 2023
Withdrawal of medication between 4 and 6 cm of dilation doesn’t appear to affect neonatal outcomes.
News
- Author:
- Randy Dotinga
Publish date: February 7, 2023
Researchers linked positive assay results to longer progression-free survival.
News
- Author:
- Randy Dotinga
Publish date: February 7, 2023
Patients who underwent short-course therapy had worse organ-preservation outcomes.
News
- Author:
- Randy Dotinga
Publish date: February 6, 2023
Previous studies and clinical observations have suggested that antibiotics during immunotherapy treatment may hasten negative outcomes.
News
- Author:
- Randy Dotinga
Publish date: February 6, 2023
A small German study found that, in patients with CLL, COVID-19 shots don’t boost B cells but they do strengthen T cells.
News
- Author:
- Randy Dotinga
Publish date: January 25, 2023
Small study shows low-dose radiotherapy improves both pain and survival in hepatocellular carcinoma.
News
- Author:
- Randy Dotinga
Publish date: January 25, 2023
A small study of the cannabis component is a ‘good first step,’ rheumatologist says.
News
- Author:
- Randy Dotinga
Publish date: January 24, 2023
A large U.S. analysis found that this newly discovered genetic disease has a estimated prevalence of 1 in 4,269 in men older than 50.
News
- Author:
- Randy Dotinga
Publish date: January 23, 2023
Skin lesions are more likely to precede systemic illness, and overall lesion numbers are lower.
News
- Author:
- Randy Dotinga
Publish date: January 20, 2023
For CML patients in remission, specialists suggest trying drug omission – which often yields good outcomes and a reprieve from side effects.
News
- Author:
- Randy Dotinga
Publish date: January 4, 2023
The doctor was accused of engaging in dialogue to respond to viewers’ online questions while a surgical procedure remained actively ongoing, among ...
News
- Author:
- Randy Dotinga
Publish date: December 22, 2022
Presidential symposium plumbs the mysteries of an “extraordinarily stealthy” virus, considers postvaccine blood clots.
